- Home
- SW vs TEVA Comparison
SW vs TEVA Comparison
Compare SW & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SW
- TEVA
- Stock Information
- Founded
- SW 1934
- TEVA 1901
- Country
- SW Ireland
- TEVA Israel
- Employees
- SW N/A
- TEVA N/A
- Industry
- SW
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- SW
- TEVA Health Care
- Exchange
- SW Nasdaq
- TEVA Nasdaq
- Market Cap
- SW 21.6B
- TEVA 18.4B
- IPO Year
- SW N/A
- TEVA N/A
- Fundamental
- Price
- SW $42.22
- TEVA $14.87
- Analyst Decision
- SW Buy
- TEVA Strong Buy
- Analyst Count
- SW 9
- TEVA 6
- Target Price
- SW $58.44
- TEVA $24.00
- AVG Volume (30 Days)
- SW 4.3M
- TEVA 12.0M
- Earning Date
- SW 05-01-2025
- TEVA 05-07-2025
- Dividend Yield
- SW 2.45%
- TEVA N/A
- EPS Growth
- SW N/A
- TEVA N/A
- EPS
- SW 0.82
- TEVA N/A
- Revenue
- SW $21,109,000,000.00
- TEVA $16,544,000,000.00
- Revenue This Year
- SW $54.95
- TEVA $5.31
- Revenue Next Year
- SW $3.60
- TEVA $1.18
- P/E Ratio
- SW $51.77
- TEVA N/A
- Revenue Growth
- SW 74.56
- TEVA 4.41
- 52 Week Low
- SW $37.01
- TEVA $12.47
- 52 Week High
- SW $56.99
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- SW N/A
- TEVA 52.87
- Support Level
- SW N/A
- TEVA $14.17
- Resistance Level
- SW N/A
- TEVA $13.74
- Average True Range (ATR)
- SW 0.00
- TEVA 0.71
- MACD
- SW 0.00
- TEVA 0.21
- Stochastic Oscillator
- SW 0.00
- TEVA 98.56
About SW Smurfit WestRock plc Ordinary Shares
Smurfit WestRock manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. After the merger of Smurfit Kappa and WestRock in summer 2024, Smurfit WestRock became the largest producer of containerboard in the world, with substantial operations in North America, South America, and Europe.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.